Home » Lycera Expands Partnership With Merck for Potential $600 Million Deal
Lycera Expands Partnership With Merck for Potential $600 Million Deal
Lycera doubled its sweet 2011 deal with Merck in a new agreement designed to expand on the companies’ prior relationship, which has centered on retinoic acid-related orphan receptor.
BioWorld
BioWorld
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May